Mount Lebanon Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Crohn's disease1 trial
• Lung cancer1 trial

Phase

• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• EMD Serono Research & Development Institute, Inc.1 trial
• Janssen Research & Development, LLC1 trial

Running trials

• Active, not recruiting

  A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT03466411· Phase 2/3· Janssen Research & Development, LLC· Source

Closed trials

• Completed

  Avelumab in First-line NSCLC (JAVELIN Lung 100)

  NCT02576574· Phase 3· EMD Serono Research & Development Institute, Inc.· Source